Physiopathological considerations in the treatment of coal workers' pneumoconiosis.
D000109:Acetylcholine; D000402:Airway Obstruction / Q000188:drug therapy; D000403:Airway Resistance; D001285:Atropine / Q000008:administration & dosage / Q000627:therapeutic use*; D001794:Blood Pressure; D001991:Bronchitis / Q000188:drug therapy; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002908:Chronic Disease; D003032:Coal Mining; D004338:Drug Combinations; D004417:Dyspnea / Q000188:drug therapy; D006801:Humans; D009921:Metaproterenol / Q000008:administration & dosage / Q000627:therapeutic use*; D011009:Pneumoconiosis / Q000188:drug therapy*; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D011651:Pulmonary Artery; D013752:Tetracycline / Q000627:therapeutic use
D001993:Bronchodilator Agents; D004338:Drug Combinations; D009921:Metaproterenol; D001285:Atropine; D011239:Prednisolone; D013752:Tetracycline; D000109:Acetylcholine